Boston Scientific
BSX
BSX
883 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 287 increasing their positions, 321 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 287 | Existing positions reduced: 321
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
42% less call options, than puts
Call options by funds: $271M | Put options by funds: $466M
Holders
883
Holding in Top 10
9
Calls
$271M
Puts
$466M
Top Buyers
| 1 | +$514M | |
| 2 | +$400M | |
| 3 | +$230M | |
| 4 |
BlackRock
New York
|
+$127M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$119M |
Top Sellers
| 1 | -$396M | |
| 2 | -$369M | |
| 3 | -$369M | |
| 4 |
Citigroup
New York
|
-$214M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$168M |